Meredith M. Regan

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · Journal of Clinical Oncology · 2009 · 2.1K citations · Full text

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Kimberly H. Allison, M. Elizabeth H. Hammond, Mitch Dowsett et al. · Journal of Clinical Oncology · 2020 · 1.4K citations · Full text

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Giuseppe Curigliano, Harold J. Burstein, Eric P. Winer et al. · Annals of Oncology · 2017 · 1.2K citations · Full text

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

Viviana Galimberti, Bernard F. Cole, Stefano Zurrida et al. · The Lancet Oncology · 2013 · 1.2K citations · Full text

Ibcsg 23–01, Surgical Pathology, Sentinel-node Micrometastases +5

Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk

Hans K. Meier-Ewert, Paul M. Ridker, Nader Rifai et al. · Journal of the American College of Cardiology · 2004 · 1.2K citations

Inflammation, Metabolic Syndrome, Sleep +11